Company Profile

Company Description

Entera Bio Ltd. is a clinical-stage biotechnology firm focused on developing orally delivered large molecule therapeutics. The company specializes in innovative drug delivery platforms that enable the absorption of proteins and peptides through the gastrointestinal tract. Its pipeline targets metabolic and bone-related disorders, aiming to provide convenient, non-invasive alternatives to injections. By leveraging proprietary technology, it seeks to improve patient compliance and expand treatment options for chronic conditions. The company collaborates with pharmaceutical partners to advance its research and bring novel therapies to market. Its work holds potential for transforming how biologics are administered, offering significant benefits to patients worldwide.